ARTICLE | Clinical News
T-SPOT: Pivotal trial started
June 29, 2015 7:00 AM UTC
Oxford Immunotec began the pivotal REACT trial of T-SPOT.CMV in up to 200 patients seropositive for CMV infection who are undergoing an allogeneic hematopoietic stem cell transplantation (HSCT). ...